Skip to main content
SpringerLink
Log in

Two-dose Ebola vaccine regimen generally well tolerated

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nyombayire J, et al. Monitoring of adverse events in recipients of the 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign Journal of Infectious Diseases : 11 Jul 2022. Available from: URL: https://doi.org/10.1093/infdis/jiac283

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Two-dose Ebola vaccine regimen generally well tolerated. Reactions Weekly 1915, 11 (2022). https://doi.org/10.1007/s40278-022-19040-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-19040-8

Search

Navigation